Dementia experts fight NHS drug ban (Telegraph) - Oct 13, 2026 - "The Telegraph can reveal that 38 leading specialists have written to Yvette Cooper, the Health Secretary, urging her to help secure NHS access to the first drugs capable of slowing the disease...The drugs, lecanemab and donanemab, were licensed in Britain in 2024 after trials found they slowed cognitive decline by around a third in patients with early-stage Alzheimer’s...However, the National Institute for health and Care Excellence (Nice) rejected their routine use on the NHS, ruling that the benefits did not justify the costs....The appraisal has been paused during commercial discussions between NHS England and the companies, the department confirmed."
Commercial • Alzheimer's Disease
|